PHGE

Biomx Ltd

$0.28

-0.01 (-2.72%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.11.2025
$15.50
(+5536.36%)
Strong Buy: 2
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
BiomX Inc. (PHGE) is a cutting-edge clinical-stage microbiome therapeutics company headquartered in Ness Ziona, Israel. The firm leverages both natural and engineered phage technologies to combat pathogenic bacterial infections and address chronic diseases linked to dysbiosis, with a robust pipeline targeting conditions such as inflammatory bowel disease, cystic fibrosis, and acne. BiomX's dedication to advancing microbial therapeutics positions it to fulfill critical unmet medical needs and spearhead innovation within the healthcare sector.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
22 EINSTEIN STREET, NESS ZIONA, ISRAEL, 7414003
Fiscal year end:
December
Market capitalization:
$8.4 Million
EBITDA:
-$33.3 Million
PERatio:
0.0
EPS:
-1.95
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.523

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 6 years:
-99%
How much will you get:
$5
Prices dates:
13-03-2019: $96.50 and 31-10-2025: $0.49